Skip to main content
Home

Main navigation

  • Top stories
  • Health
  • Crime
  • Politics
  • Business
  • Tech
  • Culture
  • Sports
  • Weird
  • 1-1-2
Image
Crucell
- Credit: Crucell in Leiden. Source:Wikimedia Commons/ Bic
Health
America
Americans infected with Ebola
anti-ebola vaccine
Atlanta
Biotech company
Canadian
Crucell
development
ebola
experimental cures
FDA
Georgia
Guinea
Leiden
Maria Pau
medication
medicine
Nigeria
outbreak
positive results
pre-clinical phase
Sierra Leone
spread
testing
TKM-Ebola
vaccine
West Africa
ZMapp
Friday, August 8, 2014 - 10:57
Share this:
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • reddit

Ebola vaccine developed in NL

A bio-tech company in Leiden, Crucell, is making headway developing a vaccine against the deadly, and fast-spreading ebola virus. In an interview with Het Financieele Dagblad, Maria Pau, head of the research program, says that data from tests on monkeys is very promising.  The virus that broke out in Guinea in March has killed almost 1000 people, leaving more than 700 still infected. In 50 to 90 percent of the cases, the virus is fatal. The race is on to develop a vaccine that can stem the spread of the virus, which has been recorded in Liberia, Sierra Leone and Nigeria so far. Pau expects that the vaccine will be ready to be tested on humans at the end of 2015 or beginning of 2016. The development of the vaccine is currently in a pre-clinical phase. The American Ministry for Public Health currently has approved an experimental form of a medicine called TKM-Ebola. According to the Canadian fabricator, the medicine helps to block the ebola virus. The fabricator said that the Food and Drug Administrator (FDA) 'verbally' agreed to remove restrictions that were standing in the way of further research and availability of the medicine. An earlier testing phase of the medicine on humans was stopped, which the fabricators of the medicine, Tekmira Pharmaceuticals may resume now that the restrictions have been lifted by the FDA. According to the pharmaceuticals company, earlier tests on healthy people were stopped by the FDA due to questions about side-effects such as nausea and low blood pressure. Two Americans who became infected by the virus in West Africa are currently being treated in Atlanta with another experimental medicine called ZMapp, which is manufactured from antibodies made by test animals. Both ZMapp and TKM-Ebola are supposed to boost the immune system as the body fights the ebola virus.

Follow us:

Latest stories

  • Dutch students less interested in German studies; Spanish gaining popularity
  • Women's prison guard suspected of sexual abuse
  • Mondriaan painting sold for $315,000 in New York
  • Netherlands teaming up with Germany, Denmark for more offshore wind farms
  • Satanic pedophile network tales cost conspiracy theorists €215,000 in damages
  • Rutte's lack of transparency a pattern, opposition says in deleted texts debate

Top stories

  • Storm warning intensified: Code orange alert issued for three Dutch provinces
  • Cabinet cutting €2.2 billion from climate, development funds to push into Defense: report
  • PM Rutte's deleted texts can't be recovered; Parliamentary debate today
  • Thunderstorms in Netherlands on Thursday: Code Yellow
  • More substantial minimum wage increase set for next year: Report
  • Labor strike to shut The Hague public transportation on June 2

© 2012-2022, NL Times, All rights reserved.

Footer menu

  • Privacy
  • Contact
  • Partner content